Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Memory and Booster of DTPw-HBV/Hib in Infants
NCT00169442Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Primary completion
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Tritanrix HepB/Hib in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Feb 2005; status: completed.
02
Drugs
Tritanrix HepB/Hib
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00169442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169442.